Measles natural history, complications and prognosis

Jump to navigation Jump to search

Measles Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Measles from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Measles natural history, complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Measles natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Measles natural history, complications and prognosis

CDC on Measles natural history, complications and prognosis

Measles natural history, complications and prognosis in the news

Blogs on Measles natural history, complications and prognosis

Directions to Hospitals Treating Measles

Risk calculators and risk factors for Measles natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Guillermo Rodriguez Nava, M.D. [2]; Vidit Bhargava, M.B.B.S [3]

Overview

Measles spreads through the air by breathing, coughing or sneezing. It is so contagious that any child who is exposed to it and is not immune will probably get the disease. The virus lives in the mucus in the nose and throat of the infected person. When that person sneezes or coughs, droplets spray into the air. The virus can live on infected surfaces for up to 2 hours and spreads so easily that people who are not immune will probably get it when they come close to someone who is infected. Measles is a disease of humans.

Complications with measles are relatively common, ranging from relatively mild and less serious diarrhea, to pneumonia and encephalitis (subacute sclerosing panencephalitis - SSPE). Complications are usually more severe amongst adults who catch the virus.

Measles itself is unpleasant, but the complications are dangerous. Six to 20 percent of the people who get the disease will get an ear infection, diarrhea, or even pneumonia. One out of 1000 people with measles will develop inflammation of the brain, and about one out of 1000 will die.

Natural History

Complications

Complications with measles are relatively common. In industrialized countries, complications occur in around 10-15% of cases, ranging from relatively mild and less serious diarrhea, to pneumonia and encephalitis (subacute sclerosing panencephalitis - SSPE). The frequency of complications in developing countries is less well known. At least three-quarters of cases in developing countries can be expected to have at least one complication and some have multiple systems involvement. Complications are usually more severe amongst adults who catch the virus. SSPE is a very rare, but fatal degenerative disease of the central nervous system that results from a measles virus infection acquired earlier in life. The first signs of SSPE may be changes in personality, a gradual onset of mental deterioration and myoclonia (muscle spasms or jerks). The diagnosis of SSPE is based on signs and symptoms and on test results, such as typical changes observed in electroencephalographs, an elevated anti-measles antibody (IgG) in the serum and cerebrospinal fluid, and typical histologic findings in brain biopsy tissue. There are reports of remission and some treatments are available; however, the average survival is one to two years. There is no evidence that measles vaccine can cause SSPE.

The fatality rate from measles for otherwise healthy people in developed countries is low: approximately 1 death per thousand cases. In underdeveloped nations with high rates of malnutrition and poor healthcare, fatality rates of 10 percent are common. In immunocompromised patients, the fatality rate is approximately 30 percent.

Serious Complications[2]

Approximately 20% of reported measles cases experience one or more complications. These complications are more common among children under 5 years of age and adults over 20 years old. Measles causes ear infections in nearly one out of every 10 children who get it. As many as one out of 20 children with measles gets pneumonia, and about one child in every 1,000 who get measles will develop encephalitis. (This is an inflammation of the brain that can lead to convulsions, and can leave your child deaf or mentally retarded.) For every 1,000 children who get measles, one or two will die from it. Measles can also make a pregnant woman have a miscarriage, give birth prematurely, or have a low-birth-weight baby. In developing countries, where malnutrition and vitamin A deficiency are prevalent, measles has been known to kill as many as one out of four people. It is the leading cause of blindness among African children. Measles kills almost 1 million children in the world each year.

Measles can also lead to life-long disabilities, including blindness, brain damage and deafness. Low vitamin A status has been associated with a higher rate of complications and a higher death rate, as it has similar pathological effects on epithelia and the immune system.

Prognosis

Measles itself is unpleasant, but the complications are dangerous. Six to 20 percent of the people who get the disease will get an ear infection, diarrhea, or even pneumonia. One out of 1000 people with measles will develop inflammation of the brain, and about one out of 1000 will die.

Most measles deaths (98%) occur in developing countries, where vitamin A deficiency is common. The case fatality rates in developing countries are normally estimated to be 3-5%, but may reach 10-30% in some situations. This compares with 0.1% in many industrialised countries. Through synergy with measles infection, vitamin A deficiency contributes to the estimated 1 million childhood deaths from measles every year. Half of the childhood corneal blindness in developing countries is attributable to vitamin A deficiency, and half to measles infection.[1]

References

  1. 1.0 1.1 "WHO guidelines for epidemic preparedness and response to measles outbreaks".
  2. "Complications of Measles".

Template:WH Template:WS